Risa Isonaka

513 total citations
25 papers, 349 citations indexed

About

Risa Isonaka is a scholar working on Neurology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Risa Isonaka has authored 25 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Surgery. Recurrent topics in Risa Isonaka's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Risa Isonaka is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Risa Isonaka collaborates with scholars based in United States, Israel and Japan. Risa Isonaka's co-authors include David S. Goldstein, Patti Sullivan, Yehonatan Sharabi, Tadashi Kawakami, Yunden Jinsmaa, Courtney Holmes, Masataka Majima, Kanako Hosono, Shuh Narumiya and Hiromi Hiruma and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Neurology.

In The Last Decade

Risa Isonaka

25 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Risa Isonaka United States 13 208 104 59 55 40 25 349
Xiaowu Hu China 12 219 1.1× 126 1.2× 23 0.4× 31 0.6× 73 1.8× 32 422
Graham Warner United Kingdom 6 74 0.4× 128 1.2× 38 0.6× 160 2.9× 59 1.5× 11 356
Sachit Shah United Kingdom 11 113 0.5× 120 1.2× 26 0.4× 59 1.1× 158 4.0× 35 456
Vera Fridman United States 9 93 0.4× 116 1.1× 23 0.4× 115 2.1× 99 2.5× 18 343
Claire Gibrat Canada 12 166 0.8× 157 1.5× 119 2.0× 57 1.0× 119 3.0× 13 518
Dominique Twelves United Kingdom 7 324 1.6× 112 1.1× 28 0.5× 59 1.1× 74 1.9× 10 508
Sheng‐Ting Li United States 10 289 1.4× 103 1.0× 348 5.9× 76 1.4× 59 1.5× 11 729
Etrat Hooshmandi Iran 11 71 0.3× 71 0.7× 22 0.4× 90 1.6× 90 2.3× 39 365
Xinlong Xu China 8 73 0.4× 50 0.5× 24 0.4× 65 1.2× 152 3.8× 11 404

Countries citing papers authored by Risa Isonaka

Since Specialization
Citations

This map shows the geographic impact of Risa Isonaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risa Isonaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risa Isonaka more than expected).

Fields of papers citing papers by Risa Isonaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risa Isonaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risa Isonaka. The network helps show where Risa Isonaka may publish in the future.

Co-authorship network of co-authors of Risa Isonaka

This figure shows the co-authorship network connecting the top 25 collaborators of Risa Isonaka. A scholar is included among the top collaborators of Risa Isonaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risa Isonaka. Risa Isonaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isonaka, Risa, Patti Sullivan, & David S. Goldstein. (2025). Pathophysiological Significance of α-Synuclein in Sympathetic Nerves. Neurology. 104(3). e210215–e210215. 2 indexed citations
2.
Goldstein, David S., Brian Walitt, Patti Sullivan, et al.. (2024). Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection. Neurology. 103(6). e209742–e209742. 2 indexed citations
3.
Goldstein, David S., Courtney Holmes, Patti Sullivan, et al.. (2023). Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases. Journal of Clinical Investigation. 134(1). 22 indexed citations
4.
Isonaka, Risa, Patti Sullivan, & David S. Goldstein. (2022). Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson’s disease: a post-mortem observational study. Translational Neurodegeneration. 11(1). 15–15. 18 indexed citations
5.
Goldstein, David S., et al.. (2021). Multiple catechols in human plasma after drinking caffeinated or decaffeinated coffee. Journal of Chromatography B. 1185. 122988–122988. 6 indexed citations
6.
Goldstein, David S., Risa Isonaka, Guillaume Lamotte, & Horacio Kaufmann. (2021). Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Clinical Autonomic Research. 31(6). 677–684. 15 indexed citations
7.
Goldstein, David S., Risa Isonaka, Courtney Holmes, Yu‐Shin Ding, & Yehonatan Sharabi. (2020). Cardiac sympathetic innervation and vesicular storage in pure autonomic failure. Annals of Clinical and Translational Neurology. 7(10). 1908–1918. 7 indexed citations
8.
Jinsmaa, Yunden, Risa Isonaka, Yehonatan Sharabi, & David S. Goldstein. (2019). 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein. Journal of Pharmacology and Experimental Therapeutics. 372(2). 157–165. 29 indexed citations
9.
Isonaka, Risa, Christopher H. Gibbons, Ningshan Wang, Roy Freeman, & David S. Goldstein. (2019). Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies. Clinical Autonomic Research. 29(6). 587–593. 7 indexed citations
10.
Jinsmaa, Yunden, Yehonatan Sharabi, Patti Sullivan, Risa Isonaka, & David S. Goldstein. (2018). 3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine. Journal of Pharmacology and Experimental Therapeutics. 366(1). 113–124. 36 indexed citations
11.
Isonaka, Risa, et al.. (2018). Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure. Clinical Autonomic Research. 28(2). 223–230. 13 indexed citations
12.
Isonaka, Risa, et al.. (2017). Development of a Smartphone App for Visualizing Heart Sounds and Murmurs. Cardiology. 137(3). 193–200. 12 indexed citations
13.
Isonaka, Risa, Courtney Holmes, Glen Cook, et al.. (2017). Pure autonomic failure without synucleinopathy. Clinical Autonomic Research. 27(2). 97–101. 18 indexed citations
14.
Hosono, Kanako, Risa Isonaka, Tadashi Kawakami, Shuh Narumiya, & Masataka Majima. (2016). Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice. PLoS ONE. 11(10). e0162532–e0162532. 37 indexed citations
15.
Goldstein, David S., Courtney Holmes, Patti Sullivan, et al.. (2016). Autoimmunity-associated autonomic failure with sympathetic denervation. Clinical Autonomic Research. 27(1). 57–62. 14 indexed citations
16.
Isonaka, Risa, et al.. (2016). Trial of real-time locating and messaging system with Bluetooth low energy. Technology and Health Care. 24(5). 689–699. 1 indexed citations
17.
Isonaka, Risa, et al.. (2013). Neurotropin inhibits axonal transport in cultured mouse dorsal root ganglion neurons. Neuroscience Letters. 543. 101–104. 10 indexed citations
20.
Isonaka, Risa, Hiromi Hiruma, & Tadashi Kawakami. (2010). Inhibition of Axonal Transport Caused by tert-Butyl Hydroperoxide in Cultured Mouse Dorsal Root Ganglion Neurons. Journal of Molecular Neuroscience. 45(2). 194–201. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026